COVID-19: Is monoclonal antibody therapy really feasible?

In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of monoclonal antibody therapy

October 15, 2020 by Newsclick

In light of US President Donald Trump’s COVID-19 treatment, the success of monoclonal antibody therapy for the treatment of the disease is being widely discussed. However, is this really a feasible option? In this interview with NewsClick, Dr. Satyajit Rath talks about the limitations of this line of treatment and the future of vaccine development for COVID-19.